In a study published in the British Journal of Nutrition, overweight and obese subjects were given either placebo or a CLA dietary supplement (Brnad: Clarinol).

The researchers report that, at the end of the study, subjects in the CLA supplemented group had significantly reduced body fat mass, compared to placebo, with the reduction most notable in the legs (0.8 kg loss versus placebo).

Lean body mass measurements also increased in the CLA group, by an average of 0.5 kg, while no significant changes in bone mineral density, blood lipid levels, or markers of inflammation.

There have been several proposed mechanisms on how CLA does this, but is still so far being researched. But the study has shown that Clarinol CLA is safe, well-tolerated and may just be the scientific backing to Clarinol’s receipt of the Slimmiing Ingredient of the Year award.

Post from: Blisstree

Conjugated Linoleic Acids Reduce Body Fat